?
Your prediction
Recce Pharmaceuticals Ltd. Stock
Pros and Cons of Recce Pharmaceuticals Ltd. in the next few years
Pros
Cons
News
Patient Dosing and Multiple Sites Activated in Registrational Phase 3 Clinical Trial for Diabetic Foot Infections in Indonesia
Highlights:
- Patient dosing is underway for Registrational Phase 3 Clinical Trial for Diabetic Foot Infections (DFI), with five (5) clinical study sites now activated across one
RECCE® 327 Topical Gel Highly Effective and Accelerated Wound Healing for Burn Wounds in Rat Infection Models
Highlights:
- RECCE® 327 Topical Gel (R327G) highly effective against Methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa infected burn wounds (in-vivo)
-
Placement of Entitlement Offer Shortfall
Highlights:
- Entitlement Offer Shortfall of approximately 26.4 million shares placed to existing institutional and sophisticated investors raising A$7.4 million
-

